With the increasing rate of Omicron in Indonesia, 121 regencies/cities are aggressively conducting weekly testing exceeding the national average. Data as of Saturday, November 19, 2022, shows the national average testing rate at 8.63 percent. This testing achievement data is calculated based on the number of people tested compared to each region's weekly target, which is then reported to the Ministry of Health.
The top five, starting from the highest percentage of people tested per week, are Semarang (157.14%), Badung (153.32%), Ciamis (133.33%), Metro City (121.14%), and Pakpak Bharat (83.93%).
Semarang is ranked first, with a weekly testing percentage of 157.14 percent. The latest positive rate is 2.93 percent. The positive rate in this region increased compared to the previous week's ratio.
Next is Badung, with a population of 727,950. In an effort to combat the Covid-19 pandemic, the weekly testing percentage reached 153.32 percent. The positive rate in this region is 8.17 percent, a decrease compared to the previous week's ratio.
Furthermore, Ciamis recorded 133.33 percent, Metro City 121.14 percent, and Pakpak Bharat 83.93 percent in weekly testing percentages.
Anticipating the impact of Omicron in various regions, based on the national Covid data recapitulation, 177 regencies/cities in Indonesia actively reported higher weekly testing percentages than before. Meanwhile, 156 other regencies/cities recorded lower weekly testing percentages compared to the previous week.
Some of the regions outside Java with the highest weekly testing percentage ratios include Badung, Metro City, and Pakpak Bharat, with weekly testing percentages of 153.32 percent, 121.14 percent, and 83.93 percent, respectively.
Although Covid-19 transmission has decreased in some areas, the government urges everyone to continue reducing Covid-19 transmission by always wearing masks, maintaining distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to suppressing the spread of the coronavirus.